The U.S. Court of Appeals for the Federal Circuit affirmed, opens new tab the invalidity of AliveCor heart-rate monitoring patents that the company had accused Apple of infringing, negating a U.S ...

AliveCor announced in September that it was planning to introduce the more accurate six-lead ECG device to compete. The company followed through with its promise and launched KardiaMobile 6L in May.